PubMed Health⌕ Search

Biomedical subjects

Franz A Mautner

Publications and source records attributed to Franz A Mautner.

5 recordsLinked to original sources
PubMed2006

Five new manganese-mu-azido 2D compounds synthesized in aqueous hydrazoic acid from pyrazine derivatives.

The syntheses, structural characterization, and magnetic behavior of five new 2D manganese(II) complexes with empirical formulas [Mn(N(3))(2)(2,6-DiMepyz)(H(2)O)](n)() (1), [Mn(N(3))(2)(Etpyz)(H(2)O)](n)() (2), [Mn(N(3))(2)(H(2)O)(2)](n)()(2,3-DiMepyz)(n)() (3), [Mn(N(3))(2)(Clpyz)(2)](n)() (4), and [Mn(N(3))(2)(Ipyz)(2)](n)() (5) (pyz = pyrazine (1,4-diazine)) are reported. 1 crystallizes in the monoclinic system, space group P2(1)/c, with unit cell parameters a = 7.513(4) A, b = 17.438(7) A, c = 8.404(4) A, beta = 94.53(4) degrees , and Z = 4. 2 crystallizes in the triclinic system, space group P, with unit cell parameters a = 7.386(2) A, b = 8.434(2) A, c = 9.442(3) A, alpha = 71.82(2) degrees , beta = 72.08(2) degrees , gamma = 88.54(2) degrees , and Z = 2. 3 crystallizes in the monoclinic system, space group C2/c, with unit cell parameters a = 20.438(7) A, b = 7.711(2) A, c = 7.457(2) A, beta = 93.76(3) degrees , and Z = 4. 4 crystallizes in the orthorhombic system, space group Pbca, with unit cell parameters a = 8.600(2) A, b = 13.440(4) A, c = 24.083(7) A, and Z = 8. 5 crystallizes in the orthorhombic system, space group Pbca, with unit cell parameters a = 8.521(2) A, b = 13.787(3) A, c = 26.237(5) A, and Z = 8. The compounds 1-5 have only azido bridging ligands. In 1-3 each manganese atom is linked to the four nearest neighbors by only end-to-end azido bridges, forming square layers. 4 and 5 show alternating end-to-end and end-on azido bridges between manganese atoms. The magnetic properties of 1-5 are reported. At high temperatures the plots of chi(M) or chi(M)T vs T for the 1-3 compounds can be fitted as homogeneous 2D systems with J = -4.9, -4.4, and -3.9 cm(-)(1) for 1-3, respectively. For 1, 3, and 5 magnetic ordering and spontaneous magnetizations is achieved below T(c) = 35, 29, and 22 K, respectively, whereas 2 and 4 do not show spontaneous magnetization up to 2 K.

Journal Article↗
PubMed2004

A two-dimensional azido-based topologic ferrimagnet.

The reported Mn(II)-azide system is the first example of a two-dimensional homometallic ferrimagnet, in which the magnetic properties are due exclusively to topological reasons related with the coordination mode of the bridging ligands; it is also the first case in which a system of this kind exhibits long range order comparable to the classical heterospin ferrimagnets.

Journal Article↗
PubMed2004

Polynuclear and 1-D derivatives of 1,3-bis(dimethylamino)-2-propanolato ligand. Structure and magnetic characterization.

Several new Cu(II) derivatives of the 1,3-bis(dimethylamino)-2-propanolato (bdmap) ligand with formula [Cu(2)(bdmap)(acac)(NH(3))(3)(MeOH)](ClO(4))(2), [Cu(2)(bdmap)(NO(2))(3)(H(2)O)](4) and [Cu(2)(bdmap)(OH)(ox)(0.5)(H(2)O)(2)](n)(ClO(4))(n)xnH(2)O were synthesized and characterized both structurally and magnetically. Dinuclear compound crystallizes in the monoclinic system, space group P2(1)/c, octanuclear compound crystallizes in the triclinic space group P1 and the 1-D alternating system crystallizes in the monoclinic system, space group P2/n. Magnetic analysis indicates strong antiferromagnetic coupling for all derivatives, mainly due to the interaction through the alkoxo O-atom of the bdmap ligand. The effect on the magnetic behaviour of the additional bridging ligands is analysed.

Journal Article↗
PubMed2003

Molecular, 1D, and 2D systems built from phenylcyanamido ligands. Syntheses, crystal structures, and characterization of their magnetic properties.

Several MnII compounds with phenylcyanamido ligands have been synthesized and characterized by means of single-crystal X-ray structural determination. The reported compounds show a wide variety of nuclearity from mononuclear and dinuclear systems to 1D chains and 2D networks in which X-phenylcyanamide (X-pcyd) anions act as the bridging ligand. Mononuclear compound [Mn(H2O)2(4-bzpy)2(3-Cl- pcyd)2] (2) crystallizes in the monoclinic system, P21/a space group, dinuclear compounds (mu 1,3-3-Cl-pcyd)2[Mn(2,2'-bpy)(3-Cl-pcyd)(MeOH)]2 (2) and (mu 1,3-3-Cl-pcyd)2[Mn(2,2'-bpy)(3-Cl-pcyd)(EtOH)]2 (3) crystallize in the triclinic system, P1 space group, 1D chain [(mu 1,3-4-Cl-pcyd)2[Mn(2,2'-bpy)]]n (4) crystallizes in the monoclinic system, /2/a space group, and 2D network [Mn(mu-4,4'-bpy)(mu 1,3-3-F-pcyd)2]n (5) crystallizes in the monoclinic system, C2 space group. Susceptibility measurements on compounds 2-4 reveal moderate antiferromagnetic coupling in all cases. MO calculations have been made to elucidate the main factors that control the superexchange pathway for this kind of ligand. Comparison of their magnetic behavior with that of related ligands such as azido and dicyanamido is reported.

Journal Article↗